28 related articles for article (PubMed ID: 10220040)
1. Synthesis and biological evaluation of prodrugs of 2-fluoro-2-deoxyribose-1-phosphate and 2,2-difluoro-2-deoxyribose-1-phosphate.
Hamon N; Quintiliani M; Balzarini J; McGuigan C
Bioorg Med Chem Lett; 2013 May; 23(9):2555-9. PubMed ID: 23541671
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of 2-amino-6-fluoro-9-(2-hydroxyethoxymethyl)purine esters as potential prodrugs of acyclovir.
Kim DK; Lee N; Im GJ; Kim HT; Kim KH
Bioorg Med Chem; 1998 Dec; 6(12):2525-30. PubMed ID: 9925308
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of 2-amino-9-(1, 3-dihydroxy-2-propoxymethyl)- 6-fluoropurine mono- and diesters as potential prodrugs of ganciclovir.
Kim DK; Chang K; Im GJ; Kim HT; Lee N; Kim KH
J Med Chem; 1999 Jan; 42(2):324-8. PubMed ID: 9925738
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of 2-amino-9-(3-acyloxymethyl-4-alkoxycarbonyloxybut-1-yl)purines and 2-amino-9-(3-alkoxycarbonyloxymethyl-4-alkoxycarbonyloxybut-1- yl)purines as potential prodrugs of penciclovir.
Kim DK; Lee N; Ryu DH; Kim YW; Kim JS; Chang K; Im GJ; Choi WS; Cho YB; Kim KH; Colledge D; Locarnini S
Bioorg Med Chem; 1999 Aug; 7(8):1715-25. PubMed ID: 10482463
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of 2-amino-9-(3-hydroxymethyl-4-alkoxycarbonyloxybut-1-yl)purines as potential prodrugs of penciclovir.
Kim DK; Lee N; Kim YW; Chang K; Kim JS; Im GJ; Choi WS; Jung I; Kim TS; Hwang YY; Min DS; Um KA; Cho YB; Kim KH
J Med Chem; 1998 Aug; 41(18):3435-41. PubMed ID: 9719596
[TBL] [Abstract][Full Text] [Related]
6. Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir].
Vere Hodge RA; Sutton D; Boyd MR; Harnden MR; Jarvest RL
Antimicrob Agents Chemother; 1989 Oct; 33(10):1765-73. PubMed ID: 2589844
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of 2-amino-6-fluoro-9-(4-hydroxy-3-hydroxymethylbut-1-yl)purine mono- and diesters as potential prodrugs of penciclovir.
Kim DK; Lee N; Kim HT; Im GJ; Kim KH
Bioorg Med Chem; 1999 Mar; 7(3):565-70. PubMed ID: 10220040
[TBL] [Abstract][Full Text] [Related]
8. Famciclovir for treatment of herpesvirus infections.
Luber AD; Flaherty JF
Ann Pharmacother; 1996 Sep; 30(9):978-85. PubMed ID: 8876860
[TBL] [Abstract][Full Text] [Related]
9. Recent clinical experience with famciclovir--a "third generation" nucleoside prodrug.
Chakrabarty A; Tyring SK; Beutner K; Rauser M
Antivir Chem Chemother; 2004 Sep; 15(5):251-3. PubMed ID: 15535046
[TBL] [Abstract][Full Text] [Related]
10. The clinical pharmacokinetics of famciclovir.
Gill KS; Wood MJ
Clin Pharmacokinet; 1996 Jul; 31(1):1-8. PubMed ID: 8827396
[TBL] [Abstract][Full Text] [Related]
11. The pharmacological profile of famciclovir.
Crumpacker C
Semin Dermatol; 1996 Jun; 15(2 Suppl 1):14-26. PubMed ID: 8840412
[TBL] [Abstract][Full Text] [Related]
12. Review of research leading to new anti-herpesvirus agents in clinical development: valaciclovir hydrochloride (256U, the L-valyl ester of acyclovir) and 882C, a specific agent for varicella zoster virus.
Purifoy DJ; Beauchamp LM; de Miranda P; Ertl P; Lacey S; Roberts G; Rahim SG; Darby G; Krenitsky TA; Powell KL
J Med Virol; 1993; Suppl 1():139-45. PubMed ID: 8245881
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
